Industry NewsFDA approves GSK’s BLENREP for the treatment of patients with relapsed or refractory multiple myeloma
Industry NewsSanofi and Regeneron provide update on Kevzara (sarilumab) Phase 3 U.S. trial in COVID-19 patients